Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
M., Trojanowski, J
Use the mL output as the primary reference and the units display as a convenience
Gregory Lubiniecki, vice president of oncology clinical research at Merck Research Laboratories, noted in a statement that prognoses are generally poor for this disease and said the company is pleased to offer a new first-line treatment option. The approval was backed by results from the Phase II/III KEYNOTE-483 trial, where Keytruda elicited a significant survival benefit for patients, cutting the risk of death by 21%
SOURCE: Hers Source: Hers
We routinely ship media that require long-term storage in the refrigerator at room temperature
US$ 21.68
US$ 27.31
US$ 24.51
US$ 27.40
US$ 26.88
